Compare PPIH & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPIH | ORMP |
|---|---|---|
| Founded | 1909 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pollution Control Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 221.6M | 197.6M |
| IPO Year | 1994 | 2010 |
| Metric | PPIH | ORMP |
|---|---|---|
| Price | $31.83 | $4.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 81.8K | ★ 160.5K |
| Earning Date | 04-16-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 6.51% |
| EPS Growth | 86.61 | ★ 412.50 |
| EPS | 0.53 | ★ 2.76 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $9.33 | N/A |
| P/E Ratio | $58.94 | ★ $1.74 |
| Revenue Growth | N/A | ★ 49.25 |
| 52 Week Low | $22.13 | $2.09 |
| 52 Week High | $36.72 | $5.47 |
| Indicator | PPIH | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 72.56 | 51.06 |
| Support Level | $29.10 | $3.91 |
| Resistance Level | $33.91 | $5.01 |
| Average True Range (ATR) | 1.16 | 0.15 |
| MACD | 0.13 | -0.02 |
| Stochastic Oscillator | 100.00 | 43.62 |
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems of the company include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, the coating and insulation of oil and gas gathering and transmission pipelines, and liquid and powder based anti-corrosion coatings applied both to the external and internal surfaces of steel pipe, including shapes such as bends, reducers, tees, and other fittings.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.